Native and Non-Native aggregation pathways of antibodies anticipated by cold-accelerated studies

Eur J Pharm Biopharm. 2023 Nov:192:174-184. doi: 10.1016/j.ejpb.2023.10.009. Epub 2023 Oct 12.

Abstract

Assessment of cold stability is essential for manufacture and commercialization of biotherapeutics. Storage stability is often estimated by measuring accelerated rates at elevated temperature and using mathematical models (as the Arrhenius equation). Although, this strategy often leads to an underestimation of protein aggregation during storage. In this work, we measured the aggregation rates of two antibodies in a broad temperature range (from 60 °C to -25 °C), using an isochoric cooling method to prevent freezing of the formulations below 0 °C. Both antibodies evidenced increasing aggregation rates when approaching extreme temperatures, because of hot and cold denaturation. This behavior was modelled using Arrhenius and Gibbs-Helmholtz equations, which enabled to deconvolute the contribution of unfolding from the protein association kinetics. This approach made possible to model the aggregation rates at refrigeration temperature (5 °C) in a relatively short timeframe (1-2 weeks) and using standard characterization techniques (SEC-HPLC and DLS).

Keywords: Accelerated degradation; Cold denaturation; Isochoric cooling method; Monoclonal antibody(s); Protein aggregation; Storage stability.

MeSH terms

  • Antibodies*
  • Cold Temperature*
  • Freezing
  • Protein Denaturation
  • Protein Stability
  • Temperature

Substances

  • Antibodies